港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

友芝友生物-B

3.800

0.000

成交量：- -

成交額：- -

市值：7.37億

市盈率：-8.69

高：3.800

開：3.800

低：3.800

收：3.800

52周最高：8.400

52周最低：3.800

股本：1.94億

香港流通股本：1.79億

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(LYR):-0.437

淨資產收益率：-704.81%

總資產收益率：-22.74%

市淨率：-12.06

市盈率(LYR):-8.69

市銷率: 9.56

資料載入中...

總覽公司新聞公告

友芝友生物-B 2026年5月股份變動月報：股本維持穩定

友芝友生物-B(02496)：M701「CD3/EpCAM雙特異性抗體」兩項臨床研究數據將於2026ASCO年會進行展示

友芝友生物-B(02496)：方麗娟獲選舉為第二屆監事會職工代表監事

友芝友生物(02496.HK)M701治療惡性腹水新藥上市申請獲受理

阿斯达克财经

友芝友生物-B更新4月股份變動月報表，股本維持穩定

友芝友生物-B(02496)：M 701兩項研究成果獲選於2026 ASCO年會進行展示

友芝友生物-B(02496)2025年業績：收入6685.8萬元研發投入回落虧損按年收窄

友芝友生物-B3月股份變動月報表，完成68,010,299股非上市股份轉換為H股

友芝友生物-B(02496)：完成H股全流通

友芝友生物-B完成已發行股本變動，H股增至1.79億股

《業績》友芝友生物(02496.HK)全年虧損收窄至8,473.2萬元人民幣

阿斯达克财经

友芝友生物-B(02496)發布年度業績年內虧損8473.2萬元按年收窄13.18%

友芝友生物-B（02496）2026年2月股份變動月報表，股本維持穩定

友芝友生物-B股價拉升17.48% 市值漲1.62億港元

友芝友生物-B(02496)：公司H股全流通獲聯交所授出上市批准

智通财经网

友芝友生物-B宣佈M701獲FDA臨床試驗批准

友芝友生物-B(02496)：M 701取得FDA的IND批准

友芝友生物-B盤中異動急速上漲7.61%

友芝友生物-B(02496)：中國證監會就公司H股全流通發出備案通知

友芝友生物(02496.HK)作價3,688萬人民幣出售武漢工業地

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02496/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02496","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","market":"HK","secType":"STK","nameCN":"友芝友生物-B","latestPrice":3.8,"timestamp":1782436804363,"preClose":3.8,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":179479113,"shares":194000000,"eps":-0.437103,"marketStatus":"休市中","change":0,"latestTime":"06-26 09:20:04","open":3.8,"high":3.8,"low":3.8,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.486413,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1782696600000},"marketStatusCode":7,"adr":0,"listingDate":1695571200000,"exchange":"SEHK","adjPreClose":3.8,"openAndCloseTimeList":[[1782437400000,1782446400000],[1782450000000,1782460800000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","floatShares":179479113,"roa":"-22.74%","roe":"-704.81%","lyrEps":-0.437103,"shares":194000000,"dividePrice":0,"high":3.8,"amplitude":0,"preClose":3.8,"low":3.8,"week52Low":3.8,"pbRate":"-12.06","psRate":"9.56","week52High":8.4,"institutionHeld":0,"latestPrice":3.8,"eps":-0.437103,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.486413,"open":3.8,"prevYearClose":8.02,"prevWeekClose":4,"prevMonthClose":4.3,"prevQuarterClose":4.13,"fiveDayClose":4,"twentyDayClose":4.3,"sixtyDayClose":4.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02496\",params:#limit:5,,,undefined,":[{"date":"2026-03-27","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-26","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-28","symbol":"02496","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"盤後","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-29","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724895000000,"name":null,"time":"","dateTimestamp":1724860800000,"actualEps":null},{"date":"2024-03-28","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711589400000,"name":null,"time":"","dateTimestamp":1711555200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02496\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02496\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02496\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02496","date":"2026-06-25","current":-7.812291,"percent":0.66568,"low":-18.565593,"twenty":-12.812038,"median":-8.30086,"eighty":-6.968548,"high":-3.741546,"avg":-9.500796,"sd":3.665955,"marketCap":736626960},"quantilePoints":[{"date":"2023-09-22","current":-15.261024,"twenty":-15.274233,"median":-15.26928,"eighty":-15.264326,"marketCap":3088019200},{"date":"2023-09-29","current":-15.292224,"twenty":-17.099581,"median":-15.293234,"eighty":-15.280473,"marketCap":3049418960},{"date":"2023-10-06","current":-15.493216,"twenty":-15.501023,"median":-15.292224,"eighty":-15.050323,"marketCap":3088019200},{"date":"2023-10-13","current":-15.380625,"twenty":-15.493216,"median":-15.348538,"eighty":-15.261024,"marketCap":3060999032},{"date":"2023-10-20","current":-10.535817,"twenty":-15.418704,"median":-15.300038,"eighty":-14.801616,"marketCap":2093571360},{"date":"2023-10-27","current":-9.759574,"twenty":-15.417248,"median":-15.292224,"eighty":-11.937608,"marketCap":1938492000},{"date":"2023-11-03","current":-9.733728,"twenty":-15.412338,"median":-15.155674,"eighty":-10.478048,"marketCap":1938492000},{"date":"2023-11-10","current":-8.275398,"twenty":-15.390041,"median":-14.508961,"eighty":-9.494912,"marketCap":1647718200},{"date":"2023-11-17","current":-8.703164,"twenty":-15.38145,"median":-11.695259,"eighty":-8.750672,"marketCap":1748519784},{"date":"2023-11-24","current":-8.421561,"twenty":-15.329285,"median":-10.573898,"eighty":-8.701771,"marketCap":1705872960},{"date":"2023-12-01","current":-7.919793,"twenty":-15.30332,"median":-10.003273,"eighty":-8.541365,"marketCap":1610886852},{"date":"2023-12-08","current":-8.497372,"twenty":-15.294595,"median":-9.516549,"eighty":-8.420238,"marketCap":1721380896},{"date":"2023-12-15","current":-8.258301,"twenty":-15.292426,"median":-9.276148,"eighty":-8.274722,"marketCap":1682611056},{"date":"2023-12-22","current":-8.349506,"twenty":-15.280473,"median":-8.776546,"eighty":-8.277258,"marketCap":1700057484},{"date":"2023-12-29","current":-8.428335,"twenty":-15.270931,"median":-8.740745,"eighty":-8.306436,"marketCap":1725257880},{"date":"2024-01-05","current":-8.249766,"twenty":-15.218884,"median":-8.699682,"eighty":-8.272694,"marketCap":1676795580},{"date":"2024-01-12","current":-8.302569,"twenty":-15.000582,"median":-8.571321,"eighty":-8.275563,"marketCap":1688426532},{"date":"2024-01-19","current":-8.113537,"twenty":-14.743085,"median":-8.513713,"eighty":-8.272694,"marketCap":1647718200},{"date":"2024-01-26","current":-7.982332,"twenty":-14.471602,"median":-8.481448,"eighty":-8.258393,"marketCap":1614763836},{"date":"2024-02-02","current":-7.992522,"twenty":-13.915342,"median":-8.424948,"eighty":-8.196137,"marketCap":1614763836},{"date":"2024-02-09","current":-8.02019,"twenty":-12.050937,"median":-8.406699,"eighty":-8.080173,"marketCap":1628333280},{"date":"2024-02-16","current":-8.343013,"twenty":-11.339581,"median":-8.370574,"eighty":-8.105196,"marketCap":1694242008},{"date":"2024-02-23","current":-8.30086,"twenty":-10.803844,"median":-8.369483,"eighty":-8.124586,"marketCap":1676795580},{"date":"2024-03-01","current":-8.247733,"twenty":-10.604956,"median":-8.362825,"eighty":-8.153154,"marketCap":1667103120},{"date":"2024-03-08","current":-8.186551,"twenty":-10.543433,"median":-8.343013,"eighty":-8.173812,"marketCap":1655472168},{"date":"2024-03-15","current":-8.155425,"twenty":-10.30474,"median":-8.311389,"eighty":-8.173276,"marketCap":1647718200},{"date":"2024-03-22","current":-7.39462,"twenty":-9.857053,"median":-8.302569,"eighty":-8.105196,"marketCap":1492638840},{"date":"2024-03-28","current":-7.61103,"twenty":-9.744066,"median":-8.301568,"eighty":-8.043049,"marketCap":1531408680},{"date":"2024-04-05","current":-7.288366,"twenty":-9.690292,"median":-8.300787,"eighty":-8.021295,"marketCap":1512023760},{"date":"2024-04-12","current":-6.976051,"twenty":-9.494912,"median":-8.295352,"eighty":-7.983468,"marketCap":1448053524},{"date":"2024-04-19","current":-6.963318,"twenty":-9.388856,"median":-8.276973,"eighty":-7.977458,"marketCap":1444176540},{"date":"2024-04-26","current":-6.971914,"twenty":-9.296949,"median":-8.272018,"eighty":-7.930221,"marketCap":1444176540},{"date":"2024-05-03","current":-6.976736,"twenty":-9.241479,"median":-8.264756,"eighty":-7.6347,"marketCap":1444176540},{"date":"2024-05-10","current":-6.960212,"twenty":-8.933122,"median":-8.256463,"eighty":-7.598809,"marketCap":1444176540},{"date":"2024-05-17","current":-6.970443,"twenty":-8.807861,"median":-8.251559,"eighty":-7.39462,"marketCap":1444176540},{"date":"2024-05-24","current":-7.095514,"twenty":-8.76114,"median":-8.247733,"eighty":-7.267873,"marketCap":1444176540},{"date":"2024-05-31","current":-7.0883,"twenty":-8.730819,"median":-8.237322,"eighty":-7.171233,"marketCap":1444176540},{"date":"2024-06-07","current":-7.097101,"twenty":-8.707372,"median":-8.195562,"eighty":-7.097101,"marketCap":1444176540},{"date":"2024-06-14","current":-7.132215,"twenty":-8.698985,"median":-8.193432,"eighty":-7.097238,"marketCap":1449992016},{"date":"2024-06-21","current":-7.988022,"twenty":-8.625304,"median":-8.18531,"eighty":-7.098087,"marketCap":1620579312},{"date":"2024-06-28","current":-7.48471,"twenty":-8.574009,"median":-8.177364,"eighty":-7.098775,"marketCap":1517839236},{"date":"2024-07-05","current":-7.715801,"twenty":-8.562528,"median":-8.159606,"eighty":-7.101937,"marketCap":1564363044},{"date":"2024-07-12","current":-7.141207,"twenty":-8.536784,"median":-8.120442,"eighty":-7.107036,"marketCap":1449992016},{"date":"2024-07-19","current":-7.131527,"twenty":-8.514561,"median":-8.053748,"eighty":-7.107036,"marketCap":1448053524},{"date":"2024-07-26","current":-7.10513,"twenty":-8.504633,"median":-8.029564,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-02","current":-7.109273,"twenty":-8.491002,"median":-8.019114,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-09","current":-7.033842,"twenty":-8.475712,"median":-7.991974,"eighty":-7.097834,"marketCap":1442238048},{"date":"2024-08-16","current":-6.879903,"twenty":-8.451599,"median":-7.985142,"eighty":-7.095806,"marketCap":1411222176},{"date":"2024-08-23","current":-6.041633,"twenty":-8.425625,"median":-7.981406,"eighty":-7.090359,"marketCap":1244511864},{"date":"2024-08-30","current":-6.047183,"twenty":-8.418914,"median":-7.97694,"eighty":-7.085583,"marketCap":1219311468},{"date":"2024-09-06","current":-6.034663,"twenty":-8.411646,"median":-7.942728,"eighty":-7.024202,"marketCap":1217372976},{"date":"2024-09-13","current":-6.050501,"twenty":-8.400619,"median":-7.919793,"eighty":-6.989131,"marketCap":1217372976},{"date":"2024-09-20","current":-5.899508,"twenty":-8.390451,"median":-7.809695,"eighty":-6.977241,"marketCap":1194111072},{"date":"2024-09-27","current":-5.635763,"twenty":-8.383344,"median":-7.722148,"eighty":-6.974189,"marketCap":1147587264},{"date":"2024-10-04","current":-6.646499,"twenty":-8.371665,"median":-7.71452,"eighty":-6.971914,"marketCap":1347251940},{"date":"2024-10-10","current":-6.670566,"twenty":-8.369919,"median":-7.665604,"eighty":-6.970443,"marketCap":1343374956},{"date":"2024-10-18","current":-5.989499,"twenty":-8.366581,"median":-7.61103,"eighty":-6.964903,"marketCap":1199926548},{"date":"2024-10-25","current":-5.941495,"twenty":-8.363757,"median":-7.592567,"eighty":-6.963278,"marketCap":1190234088},{"date":"2024-11-01","current":-5.753759,"twenty":-8.362581,"median":-7.48471,"eighty":-6.932913,"marketCap":1153402740},{"date":"2024-11-08","current":-5.323409,"twenty":-8.352088,"median":-7.478194,"eighty":-6.706839,"marketCap":1062293616},{"date":"2024-11-15","current":-4.810927,"twenty":-8.344312,"median":-7.39462,"eighty":-6.66868,"marketCap":949861080},{"date":"2024-11-22","current":-4.597104,"twenty":-8.320901,"median":-7.288282,"eighty":-6.614502,"marketCap":907214256},{"date":"2024-11-29","current":-4.511723,"twenty":-8.314189,"median":-7.193914,"eighty":-6.4628,"marketCap":889767828},{"date":"2024-12-06","current":-3.832688,"twenty":-8.309887,"median":-7.189483,"eighty":-6.054759,"marketCap":754073388},{"date":"2024-12-13","current":-3.741546,"twenty":-8.30727,"median":-7.147179,"eighty":-6.049837,"marketCap":734688468},{"date":"2024-12-20","current":-3.946605,"twenty":-8.303428,"median":-7.141207,"eighty":-6.034627,"marketCap":771519816},{"date":"2024-12-27","current":-6.936731,"twenty":-8.302316,"median":-7.140369,"eighty":-6.034555,"marketCap":1355005908},{"date":"2025-01-03","current":-7.8123,"twenty":-8.301863,"median":-7.141207,"eighty":-6.034663,"marketCap":1527531696},{"date":"2025-01-10","current":-7.782302,"twenty":-8.301426,"median":-7.145546,"eighty":-6.036057,"marketCap":1515900744},{"date":"2025-01-17","current":-7.348445,"twenty":-8.300831,"median":-7.189317,"eighty":-6.042743,"marketCap":1432545588},{"date":"2025-01-24","current":-7.302687,"twenty":-8.300293,"median":-7.192391,"eighty":-6.047847,"marketCap":1432545588},{"date":"2025-01-28","current":-7.264616,"twenty":-8.299451,"median":-7.229265,"eighty":-6.049174,"marketCap":1432545588},{"date":"2025-02-07","current":-7.236748,"twenty":-8.296655,"median":-7.256521,"eighty":-6.050501,"marketCap":1418976144},{"date":"2025-02-14","current":-6.936954,"twenty":-8.289567,"median":-7.234585,"eighty":-6.050566,"marketCap":1356944400},{"date":"2025-02-21","current":-6.209204,"twenty":-8.280918,"median":-7.193914,"eighty":-6.051176,"marketCap":1221249960},{"date":"2025-02-28","current":-5.735312,"twenty":-8.276823,"median":-7.189483,"eighty":-6.049174,"marketCap":1124325360},{"date":"2025-03-07","current":-4.382772,"twenty":-8.275728,"median":-7.147179,"eighty":-6.034591,"marketCap":862628940},{"date":"2025-03-14","current":-4.381178,"twenty":-8.27337,"median":-7.141207,"eighty":-6.005336,"marketCap":862628940},{"date":"2025-03-21","current":-4.382899,"twenty":-8.271865,"median":-7.139645,"eighty":-5.976203,"marketCap":862628940},{"date":"2025-03-28","current":-6.03007,"twenty":-8.267559,"median":-7.132215,"eighty":-5.958282,"marketCap":1184418612},{"date":"2025-04-03","current":-12.27285,"twenty":-8.275893,"median":-7.137062,"eighty":-5.959979,"marketCap":1279404720},{"date":"2025-04-11","current":-11.044555,"twenty":-8.297306,"median":-7.141207,"eighty":-5.971601,"marketCap":1143710280},{"date":"2025-04-17","current":-8.683774,"twenty":-8.301426,"median":-7.143912,"eighty":-5.986226,"marketCap":901398780},{"date":"2025-04-25","current":-8.769575,"twenty":-8.306866,"median":-7.147536,"eighty":-5.989499,"marketCap":911091240},{"date":"2025-05-02","current":-8.750975,"twenty":-8.320901,"median":-7.189649,"eighty":-5.997241,"marketCap":911091240},{"date":"2025-05-09","current":-8.320184,"twenty":-8.320865,"median":-7.193914,"eighty":-5.999307,"marketCap":872321400},{"date":"2025-05-16","current":-7.720916,"twenty":-8.320762,"median":-7.234585,"eighty":-6.005336,"marketCap":816105132},{"date":"2025-05-23","current":-7.734459,"twenty":-8.320415,"median":-7.256521,"eighty":-6.010152,"marketCap":819982116},{"date":"2025-05-30","current":-7.700604,"twenty":-8.317297,"median":-7.263991,"eighty":-6.01222,"marketCap":819982116},{"date":"2025-06-06","current":-7.681007,"twenty":-8.314485,"median":-7.286363,"eighty":-6.02333,"marketCap":819982116},{"date":"2025-06-13","current":-9.456792,"twenty":-8.320762,"median":-7.288884,"eighty":-6.03007,"marketCap":1009954332},{"date":"2025-06-20","current":-9.38443,"twenty":-8.354671,"median":-7.302687,"eighty":-6.032718,"marketCap":1000261872},{"date":"2025-06-27","current":-8.886685,"twenty":-8.370356,"median":-7.33658,"eighty":-6.034591,"marketCap":949861080},{"date":"2025-07-04","current":-8.886268,"twenty":-8.400619,"median":-7.39462,"eighty":-6.034663,"marketCap":949861080},{"date":"2025-07-11","current":-9.439834,"twenty":-8.450162,"median":-7.477671,"eighty":-6.037451,"marketCap":1008015840},{"date":"2025-07-18","current":-10.71898,"twenty":-8.504633,"median":-7.483524,"eighty":-6.043853,"marketCap":1143710280},{"date":"2025-07-25","current":-10.354306,"twenty":-8.575353,"median":-7.586326,"eighty":-6.04851,"marketCap":1108817424},{"date":"2025-08-01","current":-10.200109,"twenty":-8.700378,"median":-7.607601,"eighty":-6.050501,"marketCap":1085555520},{"date":"2025-08-08","current":-10.174658,"twenty":-8.73051,"median":-7.6347,"eighty":-6.050545,"marketCap":1085555520},{"date":"2025-08-15","current":-10.189926,"twenty":-8.755577,"median":-7.668855,"eighty":-6.050988,"marketCap":1085555520},{"date":"2025-08-22","current":-10.404516,"twenty":-8.778653,"median":-7.696508,"eighty":-6.053156,"marketCap":1104940440},{"date":"2025-08-29","current":-12.496435,"twenty":-8.886268,"median":-7.699076,"eighty":-6.05556,"marketCap":1066170600},{"date":"2025-09-05","current":-12.508831,"twenty":-8.917527,"median":-7.704882,"eighty":-6.055623,"marketCap":1066170600},{"date":"2025-09-12","current":-12.713379,"twenty":-9.283082,"median":-7.709288,"eighty":-6.056629,"marketCap":1085555520},{"date":"2025-09-19","current":-13.812899,"twenty":-9.372197,"median":-7.711903,"eighty":-6.091088,"marketCap":1178603136},{"date":"2025-09-26","current":-15.488824,"twenty":-9.421871,"median":-7.713577,"eighty":-6.168118,"marketCap":1318174560},{"date":"2025-10-03","current":-15.429223,"twenty":-9.439834,"median":-7.716349,"eighty":-6.209251,"marketCap":1316236068},{"date":"2025-10-10","current":-15.542765,"twenty":-9.48241,"median":-7.718907,"eighty":-6.209438,"marketCap":1323990036},{"date":"2025-10-17","current":-15.463777,"twenty":-9.516549,"median":-7.722508,"eighty":-6.564001,"marketCap":1316236068},{"date":"2025-10-24","current":-16.141138,"twenty":-9.993637,"median":-7.727404,"eighty":-6.587794,"marketCap":1374390828},{"date":"2025-10-31","current":-15.935241,"twenty":-10.174658,"median":-7.732892,"eighty":-6.604283,"marketCap":1358882892},{"date":"2025-11-07","current":-15.945201,"twenty":-10.180758,"median":-7.758053,"eighty":-6.609789,"marketCap":1358882892},{"date":"2025-11-14","current":-15.900146,"twenty":-10.200109,"median":-7.784219,"eighty":-6.614502,"marketCap":1358882892},{"date":"2025-11-21","current":-16.089098,"twenty":-10.29964,"median":-7.809695,"eighty":-6.640318,"marketCap":1374390828},{"date":"2025-11-28","current":-16.030869,"twenty":-10.386607,"median":-7.849274,"eighty":-6.646499,"marketCap":1374390828},{"date":"2025-12-05","current":-16.003355,"twenty":-10.404516,"median":-7.919793,"eighty":-6.658209,"marketCap":1374390828},{"date":"2025-12-12","current":-15.973808,"twenty":-10.577045,"median":-7.942728,"eighty":-6.66868,"marketCap":1374390828},{"date":"2025-12-19","current":-15.93625,"twenty":-10.714182,"median":-7.97694,"eighty":-6.670691,"marketCap":1374390828},{"date":"2025-12-24","current":-15.662693,"twenty":-10.90375,"median":-7.980005,"eighty":-6.674625,"marketCap":1355005908},{"date":"2026-01-02","current":-17.543083,"twenty":-11.095447,"median":-7.982691,"eighty":-6.684863,"marketCap":1523654712},{"date":"2026-01-09","current":-17.49951,"twenty":-11.336885,"median":-7.988022,"eighty":-6.703505,"marketCap":1523654712},{"date":"2026-01-16","current":-17.442827,"twenty":-12.451475,"median":-7.994219,"eighty":-6.740071,"marketCap":1523654712},{"date":"2026-01-23","current":-17.215232,"twenty":-12.506134,"median":-8.02019,"eighty":-6.870823,"marketCap":1502331300},{"date":"2026-01-30","current":-17.402236,"twenty":-12.672793,"median":-8.041443,"eighty":-6.879903,"marketCap":1525593204},{"date":"2026-02-06","current":-16.762691,"twenty":-13.116393,"median":-8.071832,"eighty":-6.881774,"marketCap":1473253920},{"date":"2026-02-13","current":-15.877471,"twenty":-13.767462,"median":-8.141386,"eighty":-6.889262,"marketCap":1403468208},{"date":"2026-02-20","current":-15.900374,"twenty":-14.02108,"median":-8.157515,"eighty":-6.889266,"marketCap":1403468208},{"date":"2026-02-27","current":-15.727885,"twenty":-14.413548,"median":-8.177364,"eighty":-6.902973,"marketCap":1403468208},{"date":"2026-03-06","current":-12.483086,"twenty":-14.626023,"median":-8.18531,"eighty":-6.913266,"marketCap":1104940440},{"date":"2026-03-13","current":-12.425855,"twenty":-14.413548,"median":-8.193432,"eighty":-6.925983,"marketCap":1104940440},{"date":"2026-03-20","current":-12.823206,"twenty":-14.349192,"median":-8.196999,"eighty":-6.935617,"marketCap":1135956312},{"date":"2026-03-27","current":-9.060567,"twenty":-14.332776,"median":-8.234591,"eighty":-6.936865,"marketCap":800597196},{"date":"2026-04-02","current":-8.304746,"twenty":-14.318035,"median":-8.244293,"eighty":-6.936954,"marketCap":800597196},{"date":"2026-04-10","current":-9.618041,"twenty":-14.311841,"median":-8.248749,"eighty":-6.936954,"marketCap":934353144},{"date":"2026-04-17","current":-9.614004,"twenty":-13.827239,"median":-8.252895,"eighty":-6.946166,"marketCap":934353144},{"date":"2026-04-24","current":-9.573569,"twenty":-13.812899,"median":-8.25853,"eighty":-6.950948,"marketCap":930476160},{"date":"2026-04-30","current":-9.168948,"twenty":-13.631151,"median":-8.268259,"eighty":-6.958359,"marketCap":891706320},{"date":"2026-05-08","current":-8.743175,"twenty":-13.502409,"median":-8.275398,"eighty":-6.962537,"marketCap":852936480},{"date":"2026-05-15","current":-10.226462,"twenty":-13.419752,"median":-8.281283,"eighty":-6.963278,"marketCap":1000261872},{"date":"2026-05-22","current":-10.249888,"twenty":-13.229802,"median":-8.295352,"eighty":-6.963681,"marketCap":1000261872},{"date":"2026-05-29","current":-8.511974,"twenty":-13.133287,"median":-8.300714,"eighty":-6.963936,"marketCap":833551560},{"date":"2026-06-05","current":-8.301973,"twenty":-12.941558,"median":-8.301752,"eighty":-6.964084,"marketCap":814166640},{"date":"2026-06-12","current":-8.307592,"twenty":-12.828822,"median":-8.301973,"eighty":-6.964705,"marketCap":814166640},{"date":"2026-06-18","current":-7.893055,"twenty":-12.823206,"median":-8.301937,"eighty":-6.9664,"marketCap":775396800},{"date":"2026-06-25","current":-7.5352,"twenty":-12.812038,"median":-8.30086,"eighty":-6.968548,"marketCap":736626960}],"updateTime":1782508700964},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02496\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1163663396","title":"友芝友生物-B 2026年5月股份變動月報：股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1163663396","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163663396?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 16:36","pubTimestamp":1780475794,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司于2026年6月3日披露2026年5月股份变动月报，报告期为截至2026年5月31日。根据公告披露数据，截至当月末，公司股本基本维持稳定，未发生新增发行、回购或注销股份的情况。报告显示，截至2026年5月31日，公司的法定/注册股本总额为193,849,200元人民币，其中H股179,479,113股，面值每股1元，内资股14,370,087股，面值每股1元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637311357","title":"友芝友生物-B(02496)：M701「CD3/EpCAM雙特異性抗體」兩項臨床研究數據將於2026ASCO年會進行展示","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637311357?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 20:05","pubTimestamp":1779451520,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，公司核心国家1类创新药M701“CD3/EpCAM双特异性抗体”的两项临床研究结果将于2026年美国临床肿瘤学会(ASCO)年会上进行展示：针对恶性腹水(MA)的III期注册临床研究、针对非小细胞肺癌(NSCLC)相关恶性胸水(MPE)的II期临床研究。M701的上市申请已于2026年5月获中国国家药品监督管理局药品审评中心(CDE) 受理，有望成为中国首个恶性胸腹水标准治疗方案。相比欧盟获批的卡妥索单抗，M701展现出更优的安全性与切实的临床可及性;相比穿刺引流或局部化疗，M701则体现出更高的有效率和更持久的积液控制能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635704166","title":"友芝友生物-B(02496)：方麗娟獲選舉為第二屆監事會職工代表監事","url":"https://stock-news.laohu8.com/highlight/detail?id=2635704166","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635704166?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 16:35","pubTimestamp":1778834112,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，石剑博士(石博士)因个人职业发展原因而辞去本公司职工代表监事职务，自2026年5月15日起生效。本公司抗体平台部副总监方丽娟女士(方女士)于2026年5月15日获职工代表大会民主选举为第二届监事会职工代表监事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633114816","title":"友芝友生物(02496.HK)M701治療惡性腹水新藥上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2633114816","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633114816?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 17:35","pubTimestamp":1778146500,"startTime":"0","endTime":"0","summary":"友芝友生物-B(02496.HK) 公布，自主研发的双特异性抗体药物M701治疗晚期上皮性恶性肿瘤导致的恶性腹水的新药上市申请已获得国家药监局正式受理。M701正在中国开展针对恶性腹水及恶性胸水的多项不同阶段的临床试验，包括一项针对上皮性实体瘤引发的恶性腹水的关键III期临床试验，其新药上市申请已获国家药监局的正式受理，以及一项针对非小细胞肺癌引发的恶性胸水的II期临床试验，目前已完成受试者入组。(ha/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1523359/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1523359/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161026826","title":"友芝友生物-B更新4月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1161026826","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161026826?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 16:53","pubTimestamp":1778057634,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司于2026年5月6日发布截至2026年4月30日止的股份变动月报表。根据公告，报告期内公司已发行股份及注册股本均无变化，股本维持稳定。报告期末，H股已发行股份数为179,479,113股，内资股已发行股份数为14,370,087股，合计已发行股份总数保持在193,849,200股，未发生新增发行、回购或注销等变动。在购股权计划方面，公司于2024年6月27日通过了2024年H股购股权计划，报告期内无因期权行使而产生的新股发行，亦无库存股份变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629009835","title":"友芝友生物-B(02496)：M 701兩項研究成果獲選於2026 ASCO年會進行展示","url":"https://stock-news.laohu8.com/highlight/detail?id=2629009835","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629009835?lang=zh_tw&edition=fundamental","pubTime":"2026-04-23 19:36","pubTimestamp":1776944163,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，本公司核心创新双特异性抗体产品(M 701)两项临床研究成果成功入选2026年美国临床肿瘤学会(ASCO)年会。其中，M 701用于恶性腹水的III期临床研究成果入选大会临床科学研讨会口头报告;同时，M 701用于恶性胸腔积液的II期临床研究成果入选大会海报展示。这是M 701项目在国际肿瘤学术舞台上的又一重要里程碑，体现了M 701在恶性浆膜腔积液治疗领域持续获得国际学术界关注与认可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133540584","title":"友芝友生物-B(02496)2025年業績：收入6685.8萬元 研發投入回落 虧損按年收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1133540584","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133540584?lang=zh_tw&edition=fundamental","pubTime":"2026-04-16 23:15","pubTimestamp":1776352515,"startTime":"0","endTime":"0","summary":"2025年度，友芝友生物-B收入为人民币6685.8万元，较2024年的1.0781亿元下降约38.0%。毛利为1073.5万元，同比下滑87.4%，主要因收入规模收缩及成本增加所致。年内除税前亏损约8473.2万元，相比2024年收窄13.2%，研发支出则由1.6499亿元降至7819.8万元，显示公司在控制费用方面取得一定成效。同时，公司现金及现金等价物在年末降至1.00065亿元，流动资产与流动负债对比呈现一定压力，资产净值由2024年底的正值转为负数。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132405667","title":"友芝友生物-B3月股份變動月報表，完成68,010,299股非上市股份轉換為H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1132405667","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132405667?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 17:36","pubTimestamp":1775640970,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司于2026年4月8日发布截至2026年3月31日的股份变动月报表。月报显示，公司于报告期内完成非上市股份转换为H股的相关工作，股本结构随之发生明显变动。根据公告，报告期内H股数量由此前的111,468,814股增至179,479,113股，增加部分为68,010,299股；与此同时，内资股数量从75,510,642股降至14,370,087股，非上市外资股则由6,869,744股降至0。公司在完成上述转换后，截至3月底的法定注册资本合计为193,849,200股，标志着H股全流通顺利完成。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623390729","title":"友芝友生物-B(02496)：完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2623390729","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623390729?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 16:57","pubTimestamp":1774861075,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，于2026年3月30日完成将合共6801.03万股非上市股份转换为H股，而转换后H股将于2026年3月31日上午九时正于联交所开始上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156483037","title":"友芝友生物-B完成已發行股本變動，H股增至1.79億股","url":"https://stock-news.laohu8.com/highlight/detail?id=1156483037","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156483037?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 16:57","pubTimestamp":1774861024,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药股份有限公司（股票名称：友芝友生物-B，股票代码：02496）于2026年3月30日发布翌日披露报表，公告其已发行股本发生变动。根据公告，公司将61,140,555股内资股和6,869,744股非上市外资股转换为共计68,010,299股H股。\n此次股本变动占本次变动前公司已发行股份（不含库藏股）约61.01%，完成后公司H股由111,468,814股增加至179,479,113股，内资股和非上市外资股则相应减少。公司在公告中确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规，相关董事会授权程序已完成。\n公告由联席公司秘书郑建华签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623672753","title":"《業績》友芝友生物(02496.HK)全年虧損收窄至8,473.2萬元人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2623672753","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623672753?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 10:52","pubTimestamp":1774839120,"startTime":"0","endTime":"0","summary":"友芝友生物－Ｂ(02496.HK) 公布截至去年12月底止全年业绩，营业额6,685.8万元人民币(下同)，按年跌38%。亏损收窄至8,473.2万元，上年同期蚀9,759.9万元；每股亏损0.44元。不派息。(ha/u)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2025/08/26中期业绩无派息2025/03/28末期业绩无派息2024/08/29中期业绩无派息2024/03/28末期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513983/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513983/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["CYB","02496","CNHmain","MCNHmain","BK1161","MUCmain","UCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622822490","title":"友芝友生物-B(02496)發布年度業績 年內虧損8473.2萬元 按年收窄13.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822490","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622822490?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 21:29","pubTimestamp":1774618178,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布截至2025年12月31日止年度业绩，该集团取得收入6685.8万元(人民币，下同)，同比减少37.99%;年内亏损8473.2万元，同比收窄13.18%;每股基本亏损0.44元。公告称，集团于报告期的亏损减少主要是由于收入减少人民币4100万元;于报告期内的收入成本较同期增加人民币3340万元;及于报告期内的研发开支较同期减少人民币8680万元。上述各项抵销，使得报告期的亏损及综合开支总额较同期有所减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128838338","title":"友芝友生物-B（02496）2026年2月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1128838338","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128838338?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 16:52","pubTimestamp":1772614325,"startTime":"0","endTime":"0","summary":"友芝友生物-B（02496）于2026年3月4日提交的月报显示，截至2026年2月28日，公司注册股本合计人民币193,849,200元，较上月无任何变动。H股数量维持111,468,814股，内资股数量为75,510,642股，非上市外资股数量为6,869,744股，三类股份的已发行数量均无新增或回购活动。\n公司已于2024年6月27日采纳2024年H股购股权计划，目前未见因行使期权而导致的股份发行或库存股转让数量变动。公告同时提及，获联交所批准转换为H股的68,010,299股非上市股份仍在办理转换过程中。\n公司确认符合香港联交所上市规则对公众持股量的要求。公告由联席公司秘书郑建华签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616551052","title":"友芝友生物-B股價拉升17.48% 市值漲1.62億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616551052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616551052?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 11:40","pubTimestamp":1772595622,"startTime":"0","endTime":"0","summary":"2026年03月04日临近午盘11时40分，友芝友生物-B股票出现异动，股价急速拉升17.48%。截至发稿，该股报8.400港元/股，成交量3600股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1.008万港元。友芝友生物-B股票所在的生物技术行业中，整体跌幅为3.57%。其相关个股中，昭衍新药、永泰生物-B、北海康成-B涨幅较大，振幅较大的相关个股有帝王国际投资、轩竹生物-B、银诺医药-B，振幅分别为15.60%、12.79%、10.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030411402297a7f20a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030411402297a7f20a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608360867","title":"友芝友生物-B(02496)：公司H股全流通獲聯交所授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360867","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608360867?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 22:06","pubTimestamp":1770214006,"startTime":"0","endTime":"0","summary":"友芝友生物-B(02496)发布公告，公司已于2026年2月4日获联交所批准6801.03万股H股( \n相当于根据转换并上市将予转换的公司非上市股份总数 )上市及买卖。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_13.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_13.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"友芝友生物-B(02496)：公司H股全流通获联交所授出上市批准","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195242271","title":"友芝友生物-B宣佈M701獲FDA臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1195242271","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195242271?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 00:36","pubTimestamp":1770136568,"startTime":"0","endTime":"0","summary":"2月3日，武汉友芝友生物制药股份有限公司（02496.HK）宣布，其研发的M701已获得美国食品药品监督管理局（FDA）的新药临床试验申请（IND）批准。此次获批标志着该药物可进入临床开发阶段，为公司创新药管线的国际化布局奠定重要基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608824493","title":"友芝友生物-B(02496)：M 701取得FDA的IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2608824493","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608824493?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 18:09","pubTimestamp":1770113353,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布公告，于2026年1月31日，注射用重组抗上皮细胞黏附分子和分化簇3人鼠嵌合双特异性抗体获美国食品药物管理局临床试验申请批准，标志着这款针对恶性胸腔积液的创新疗法迈入国际化临床开发新阶段，为全球患者带来新希望。M 701精准靶向Ep CAM和CD3，其中Ep CAM在上皮来源恶性胸腔积液肿瘤细胞中高频表达，是关键治疗靶点;CD3可激活机体抗肿瘤免疫，二者协同实现精准治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","IND","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606766165","title":"友芝友生物-B盤中異動 急速上漲7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606766165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606766165?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 10:31","pubTimestamp":1769567516,"startTime":"0","endTime":"0","summary":"2026年01月28日早盘10时31分，友芝友生物-B股票出现异动，股价大幅拉升7.61%。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，友芝友生物-B、MIRXES-B、创胜集团-B涨幅较大，振幅较大的相关个股有旺山旺水-B、维亚生物、复宏汉霖，振幅分别为12.30%、7.60%、7.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128103156a6b53e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128103156a6b53e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606221662","title":"友芝友生物-B(02496)：中國證監會就公司H股全流通發出備案通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2606221662","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606221662?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 18:01","pubTimestamp":1769421689,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布公告，本公司近期已就H股全流通向中国证监会提交备案。根据备案通知，有关转换并上市的中国证监会备案已告完成，倘本公司拟于备案通知发出日期起 12个月内未完成转换并上市，拟继续推进的，则需向中国证监会提交更新后的备案。截至本公告日期，H股全流通及转换并上市的实施计划详情尚未最终落实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"友芝友生物-B(02496)：中国证监会就公司H股全流通发出备案通知","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606301252","title":"友芝友生物(02496.HK)作價3,688萬人民幣出售武漢工業地","url":"https://stock-news.laohu8.com/highlight/detail?id=2606301252","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606301252?lang=zh_tw&edition=fundamental","pubTime":"2026-01-25 19:07","pubTimestamp":1769339220,"startTime":"0","endTime":"0","summary":"友芝友生物－Ｂ(02496.HK) 公布，向武汉依瑞德转让位于湖北省武汉市东、地盘面积约2,5533平方米的未使用工业用连建筑物，现金代价3,688万人民币。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230918101532905_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498487/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498487/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["CNHmain","BK1161","02496","UCmain","MUCmain","MCNHmain","CYB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}